Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment

How to further optimize the combination of radiotherapy and immunotherapy is among the current hot topics in cancer treatment. In addition to adopting the preferred dose-fractionation of radiotherapy or the regimen of immunotherapy, it is also very promising to add antiangiogenic therapy to this com...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meng, Zhai, Yirui, Hui, Zhouguang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681994/
https://www.ncbi.nlm.nih.gov/pubmed/36439496
http://dx.doi.org/10.3389/fonc.2022.978608
_version_ 1784834747747270656
author Yuan, Meng
Zhai, Yirui
Hui, Zhouguang
author_facet Yuan, Meng
Zhai, Yirui
Hui, Zhouguang
author_sort Yuan, Meng
collection PubMed
description How to further optimize the combination of radiotherapy and immunotherapy is among the current hot topics in cancer treatment. In addition to adopting the preferred dose-fractionation of radiotherapy or the regimen of immunotherapy, it is also very promising to add antiangiogenic therapy to this combination. We expound the application basis of cancer radiotherapy combined with immunotherapy and antiangiogenic therapy.
format Online
Article
Text
id pubmed-9681994
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-96819942022-11-24 Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment Yuan, Meng Zhai, Yirui Hui, Zhouguang Front Oncol Oncology How to further optimize the combination of radiotherapy and immunotherapy is among the current hot topics in cancer treatment. In addition to adopting the preferred dose-fractionation of radiotherapy or the regimen of immunotherapy, it is also very promising to add antiangiogenic therapy to this combination. We expound the application basis of cancer radiotherapy combined with immunotherapy and antiangiogenic therapy. Frontiers Media S.A. 2022-11-09 /pmc/articles/PMC9681994/ /pubmed/36439496 http://dx.doi.org/10.3389/fonc.2022.978608 Text en Copyright © 2022 Yuan, Zhai and Hui https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Yuan, Meng
Zhai, Yirui
Hui, Zhouguang
Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
title Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
title_full Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
title_fullStr Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
title_full_unstemmed Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
title_short Application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
title_sort application basis of combining antiangiogenic therapy with radiotherapy and immunotherapy in cancer treatment
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9681994/
https://www.ncbi.nlm.nih.gov/pubmed/36439496
http://dx.doi.org/10.3389/fonc.2022.978608
work_keys_str_mv AT yuanmeng applicationbasisofcombiningantiangiogenictherapywithradiotherapyandimmunotherapyincancertreatment
AT zhaiyirui applicationbasisofcombiningantiangiogenictherapywithradiotherapyandimmunotherapyincancertreatment
AT huizhouguang applicationbasisofcombiningantiangiogenictherapywithradiotherapyandimmunotherapyincancertreatment

Ejemplares similares